Back

Ibrutinib and acalabrutinib use and risk of incident atrial fibrillation: a propensity-matched analysis

20 June 2025 (00:00 - 00:00)
Organised by: Logo
Congress Presentation Part of: Resonating rhythms: navigating arrhythmia challenges in cardio-oncology Diagnosis and Management of Cardiovascular Disease in Patients with Cancer CCO Premium Access ESC Cardio-Oncology 2025 Council of Cardio-Oncology

About the speaker

Photo
Professor Joachim Alexandre

University Hospital of Caen, Caen (France)

5 More presentations in this session

Presentation thumbnail
Exploring arrhythmias in children, adolescents and young adults with cancer: the Rebuc study perspective.
Mr P. Mallios (Norrkoping, SE)
Abstract Slides
Presentation thumbnail
Atrial arrhythmia associated with cdk4/6 inhibitor use in patients with hormone receptor-positive / HER2-negative breast cancer
Doctor N. Davis (Rochester, US)
Abstract Slides
Presentation thumbnail
Innovative ablation technique for cancer patients: assessing pulsed field ablation in atrial fibrillation
Doctor M. Garcia De Yebenes Castro (Madrid, ES)
Abstract Slides
Presentation thumbnail
Left atrial appendage closure in patients with cancer
Doctor A. De La Fuente Villena (Madrid, ES) Doctor M. Garcia De Yebenes Castro (Madrid, ES)
Abstract Slides
Presentation thumbnail
Use of direct oral anticoagulants in patients with atrial fibrillation and cancer: a subanalysis of the nationwide Italian START registry.
Doctor V. Cormaci (Rome, IT)
Abstract Slides

Access the full session

Session thumbnail
Resonating rhythms: navigating arrhythmia challenges in cardio-oncology

The Event

Event poster

ESC Cardio-Oncology 2025

20 June - 21 June 2025

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources